{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T21:16:50Z","timestamp":1777238210774,"version":"3.51.4"},"reference-count":30,"publisher":"MDPI AG","issue":"22","license":[{"start":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T00:00:00Z","timestamp":1637107200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005297","name":"Medical University of Bialystok","doi-asserted-by":"publisher","award":["SUB\/1\/DN\/21\/004\/1143"],"award-info":[{"award-number":["SUB\/1\/DN\/21\/004\/1143"]}],"id":[{"id":"10.13039\/501100005297","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005297","name":"Medical University of Bialystok","doi-asserted-by":"publisher","award":["SUB\/1\/DN\/21\/001\/1143"],"award-info":[{"award-number":["SUB\/1\/DN\/21\/001\/1143"]}],"id":[{"id":"10.13039\/501100005297","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Inflammatory bowel disease (IBD) in children is frequently associated with liver pathology manifested as transient elevation of liver enzymes or specified liver diseases. The aim of the study was to evaluate the prevalence and the type of liver pathology in children with IBD within 2 years\u2019 follow-up after the IBD diagnosis. Methods: We retrospectively reviewed records of children with IBD. Liver pathology was defined as elevated activity of liver enzymes (alanine transaminase (ALT) and\/or gamma-glutamyl transpeptidase (GGT)) and bilirubin concentration in serum and\/or as pathological changes of the organ on imaging tests (abdominal ultrasound and\/or magnetic resonance cholangiopancreatography) or on liver histology performed when indicated. Results: Liver pathology was detected in 21 from 119 children (18%), including 7 (17%) with Crohn\u2019s disease (CD) and 14 (18%) with ulcerative colitis (UC). Specified diagnosis for liver abnormality was found in 14 of 21 children (67%), including primary sclerosing cholangitis (PSC, 19%), non-alcoholic fatty liver disease (NAFLD, 19%), autoimmune sclerosing cholangitis (ASC, 5%), autoimmune hepatitis (AIH, 5%), cholelithiasis (5%), drug-induced liver disease (9%) and viral infection (herpes simplex virus, 5%). Most patients manifested mild IBD or were in clinical remission at the time of liver pathology diagnosis. 14% of patients with liver disease (including only cases with PSC) were diagnosed before IBD, 33% at the same time, and 52% in the later period. Patients with the specified diagnosis of liver pathology were younger, had higher ALT activity and more often demonstrated liver abnormalities on imaging tests. UC patients with idiopathic elevation of liver enzymes had higher pediatric ulcerative colitis activity index scores compared to children with specified liver disease. Conclusions: Liver pathology was observed in a significant percentage of children with IBD in our study. The majority of cases of hepatobiliary abnormalities were detected after diagnosis of IBD; therefore, children with IBD should undergo routine monitoring of liver enzymes.<\/jats:p>","DOI":"10.3390\/jcm10225359","type":"journal-article","created":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T09:16:11Z","timestamp":1637140571000},"page":"5359","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Liver Pathology in Children with Diagnosed Inflammatory Bowel Disease\u2014A Single Center Experience"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1671-6578","authenticated-orcid":false,"given":"Urszula","family":"Daniluk","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Gastroenterology, Hepatology, Nutrition and Allergology, Medical University of Bialystok, 15-274 Bialystok, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamila","family":"Kwiatek-Sredzinska","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Gastroenterology, Hepatology, Nutrition and Allergology, Medical University of Bialystok, 15-274 Bialystok, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr","family":"Jakimiec","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Gastroenterology, Hepatology, Nutrition and Allergology, Medical University of Bialystok, 15-274 Bialystok, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0787-1461","authenticated-orcid":false,"given":"Jaroslaw","family":"Daniluk","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Internal Medicine, Medical University of Bialystok, 15-276 Bialystok, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandra","family":"Czajkowska","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Gastroenterology, Hepatology, Nutrition and Allergology, Medical University of Bialystok, 15-274 Bialystok, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dariusz","family":"Lebensztejn","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Gastroenterology, Hepatology, Nutrition and Allergology, Medical University of Bialystok, 15-274 Bialystok, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,11,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Alemany-Cosme, E., S\u00e1ez-Gonz\u00e1lez, E., Moret, I., Mateos, B., Iborra, M., Nos, P., Sandoval, J., and Beltr\u00e1n, B. (2021). Oxidative Stress in the Pathogenesis of Crohn\u2019s Disease and the Interconnection with Immunological Response, Microbiota, External Environmental Factors, and Epigenetics. Antioxidants, 10.","DOI":"10.3390\/antiox10010064"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/ibd.21820","article-title":"Incidence of liver toxicity in inflammatory bowel disease patients treated with methotrexate: A meta-analysis of clinical trials","volume":"18","author":"Khan","year":"2012","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Filimoniuk, A., Blachnio-Zabielska, A., Imierska, M., Lebensztejn, D.M., and Daniluk, U. (2020). Sphingolipid Analysis Indicate Lactosylceramide as a Potential Biomarker of Inflammatory Bowel Disease in Children. Biomolecules, 10.","DOI":"10.3390\/biom10071083"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.advms.2019.12.009","article-title":"Metabolomic profiling in children with inflammatory bowel disease","volume":"65","author":"Filimoniuk","year":"2020","journal-title":"Adv. Med. Sci."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2147\/JIR.S288742","article-title":"Cathelicidin-A Novel Potential Marker of Pediatric Inflammatory Bowel Disease","volume":"14","author":"Krawiec","year":"2021","journal-title":"J. Inflamm. Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1097\/MPG.0000000000000672","article-title":"Incidence, pattern, and etiology of elevated liver enzymes in pediatric inflammatory bowel disease","volume":"60","author":"Pusateri","year":"2015","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1572-0241.2006.00947.x","article-title":"Abnormal hepatic biochemistries in patients with inflammatory bowel disease","volume":"102","author":"Mendes","year":"2007","journal-title":"Am. J. Gastroenterol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/MPG.0000000000000409","article-title":"Liver enzyme elevations within 3 months of diagnosis of inflammatory bowel disease and likelihood of liver disease","volume":"59","author":"Goyal","year":"2014","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1097\/MIB.0000000000000558","article-title":"Abnormal Liver Biochemistry Is Common in Pediatric Inflammatory Bowel Disease: Prevalence and Associations","volume":"21","author":"Valentino","year":"2015","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/apt.12794","article-title":"Systematic review: The epidemiology of the hepatobiliary manifestations in patients with inflammatory bowel disease","volume":"40","author":"Gizard","year":"2014","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S1665-2681(19)31615-1","article-title":"Prevalence and factors associated with the presence of abnormal function liver tests in patients with ulcerative colitis","volume":"9","author":"Uribe","year":"2010","journal-title":"Ann. Hepatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"7604939","DOI":"10.1155\/2019\/7604939","article-title":"Frequency of Hepatobiliary Manifestations and Concomitant Liver Disease in Inflammatory Bowel Disease Patients","volume":"2019","author":"Silva","year":"2019","journal-title":"Biomed. Res. Int."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"203","DOI":"10.5114\/ceh.2019.87632","article-title":"Hepatobiliary manifestations of inflammatory bowel disease in children","volume":"5","author":"Kucharska","year":"2019","journal-title":"Clin. Exp. Hepatol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"689","DOI":"10.3109\/00365528009181516","article-title":"Sclerosing cholangitis in ulcerative colitis","volume":"15","author":"Schrumpf","year":"1980","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1080\/00365529850166275","article-title":"Hepatobiliary alterations in patients with inflammatory bowel disease: A multicenter study. Caprilli & Gruppo Italiano Studio Colon-Retto","volume":"33","author":"Riegler","year":"1998","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/00004836-200305000-00012","article-title":"Sonographic prevalence of liver steatosis and biliary tract stones in patients with inflammatory bowel disease: Study of 511 subjects at a single center","volume":"36","author":"Bargiggia","year":"2003","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/BF02591669","article-title":"Detection of liver involvement in inflammatory bowel disease by abdominal ultrasound scan","volume":"21","author":"Torgano","year":"1992","journal-title":"Int. J. Clin. Lab. Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/MPG.0b013e3181ca4db4","article-title":"Extraintestinal manifestations of pediatric inflammatory bowel disease and their relation to disease type and severity","volume":"51","author":"Dotson","year":"2010","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/MPG.0000000000000239","article-title":"ESPGHAN revised porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents","volume":"58","author":"Levine","year":"2014","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/MPG.0000000000001801","article-title":"Diagnosis and Management of Pediatric Autoimmune Liver Disease: ESPGHAN Hepatology Committee Position Statement","volume":"66","author":"Vergani","year":"2018","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/MPG.0000000000001482","article-title":"NASPGHAN Clinical Practice Guideline for the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease in Children: Recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN)","volume":"64","author":"Vos","year":"2017","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1600-0676.1990.tb00465.x","article-title":"Liver damage in juvenile inflammatory bowel disease","volume":"10","author":"Nemeth","year":"1990","journal-title":"Liver"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.advms.2018.08.001","article-title":"The combination of fecal calprotectin with ESR, CRP and albumin discriminates more accurately children with Crohn\u2019s disease","volume":"64","author":"Daniluk","year":"2019","journal-title":"Adv. Med. Sci."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1002\/ibd.21585","article-title":"Prevalence and epidemiology of overweight and obesity in children with inflammatory bowel disease","volume":"17","author":"Long","year":"2011","journal-title":"Inflamm. Bowel. Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/s12944-018-0855-9","article-title":"Increased serum concentration of ceramides in obese children with nonalcoholic fatty liver disease","volume":"17","author":"Wasilewska","year":"2018","journal-title":"Lipids. Health Dis."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.12659\/MSM.896116","article-title":"Inflammatory and Lipid-Associated Markers of Cardiovascular Diseases in Children with First Exacerbation of Inflammatory Bowel Disease","volume":"22","author":"Krawiec","year":"2016","journal-title":"Med. Sci. Monit."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jpeds.2012.03.043","article-title":"Premature subclinical atherosclerosis in pediatric inflammatory bowel disease","volume":"161","author":"Aloi","year":"2012","journal-title":"J. Pediatr."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1002\/hep.21537","article-title":"Incidence and risk factors for gallstones in patients with inflammatory bowel disease: A large case-control study","volume":"45","author":"Parente","year":"2007","journal-title":"Hepatology"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"62","DOI":"10.7812\/TPP\/12-144","article-title":"Probiotics and liver disease","volume":"17","author":"Sharma","year":"2013","journal-title":"Perm. J."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2478\/v10039-012-0025-7","article-title":"Probiotic-induced apoptosis and its potential relevance to mucosal inflammation of gastrointestinal tract","volume":"57","author":"Daniluk","year":"2012","journal-title":"Adv. Med. Sci."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/10\/22\/5359\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:31:44Z","timestamp":1760167904000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/10\/22\/5359"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,17]]},"references-count":30,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2021,11]]}},"alternative-id":["jcm10225359"],"URL":"https:\/\/doi.org\/10.3390\/jcm10225359","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,17]]}}}